Skip to main content
NIH funding notice RFA-DK-16-007

Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3)

Closed on November 14, 2016.

Posted
June 15, 2016
Close date
November 14, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,882,247 in first-year total cost, median $2,882,247.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-9 (M1)]1

Most frequent institutions

  1. NYU WINTHROP HOSPITAL1
Competing awards under RFA-DK-16-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Cohort1DP3DK114812-01JACOBSON, ALAN MNYU WINTHROP HOSPITAL, NY$2,882,247ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DK-16-007: Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3) | ScienceDex | ConductScience